Profil
Ingrid C.
Choong worked as a Senior Scientist at Sunesis Pharmaceuticals, Inc. from 1999 to 2008.
She then served as an Investor Relations Officer at Eiger BioPharmaceuticals, Inc. In 2008, she returned to Eiger BioPharmaceuticals, Inc. as the SVP-Clinical Development & Head-Investor Relations.
In terms of education, Dr. Choong obtained an undergraduate degree from the California Institute of Technology and a doctorate from the University of California, Berkeley.
Anciens postes connus de Ingrid Choong
| Sociétés | Poste | Fin |
|---|---|---|
| EIGER BIOPHARMACEUTICALS | Directeur Technique/Scientifique/R&D | 01/09/2023 |
Eiger BioPharmaceuticals, Inc. /Old/
Eiger BioPharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Investor Relations Contact | 29/03/2016 |
| VIRACTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2008 |
Formation de Ingrid Choong
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Sunesis Pharmaceuticals, Inc.
Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics for treatment of solid and hematologic cancers | Health Technology |
Eiger BioPharmaceuticals, Inc. /Old/
Eiger BioPharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eiger BioPharmaceuticals, Inc.
Eiger BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat and cure hepatitis delta virus and other serious diseases | Health Technology |
















